Diagnostics & Research
The Diagnostics & Research industry has a total of 46 stocks, with a combined market cap of $856.84 billion, total revenue of $173.01 billion and a weighted average PE ratio of 47.78.
Market Cap
856.84B
Revenue
173.01B
Profits
17.93B
PE Ratio
47.78
Profit Margin
10.37%
Dividend Yield
0.20%
46 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | TMO | Thermo Fisher Scientific Inc. | 232.47B | -0.08% | 1,727,092 | 46.34B |
| 2 | DHR | Danaher Corporation | 151.22B | -1.71% | 2,510,264 | 25.11B |
| 3 | NTRA | Natera, Inc. | 47.24B | -1.30% | 1,219,475 | 2.71B |
| 4 | IDXX | IDEXX Laboratories, Inc. | 44.08B | 0.46% | 388,922 | 4.55B |
| 5 | A | Agilent Technologies, Inc. | 43.33B | -3.50% | 3,945,882 | 7.23B |
| 6 | IQV | IQVIA Holdings Inc. | 42.84B | 0.16% | 903,047 | 16.98B |
| 7 | WAT | Waters Corporation | 40.36B | 0.01% | 443,563 | 4.64B |
| 8 | ILMN | Illumina, Inc. | 33.71B | 1.74% | 2,250,585 | 4.49B |
| 9 | MTD | Mettler-Toledo International Inc. | 28.03B | 0.26% | 164,272 | 4.13B |
| 10 | LH | Labcorp Holdings Inc. | 27.52B | 0.89% | 369,405 | 14.35B |
| 11 | DGX | Quest Diagnostics Incorporated | 26.92B | -0.21% | 837,729 | 11.56B |
| 12 | GH | Guardant Health, Inc. | 21.90B | -4.40% | 2,212,199 | 1.18B |
| 13 | MEDP | Medpace Holdings, Inc. | 17.31B | -0.12% | 186,214 | 2.78B |
| 14 | CRL | Charles River Laboratories International, Inc. | 14.25B | 1.15% | 699,363 | 4.00B |
| 15 | RVTY | Revvity, Inc. | 13.73B | -1.40% | 1,505,363 | 2.91B |
| 16 | ICLR | ICON Public Limited Company | 13.38B | 0.73% | 420,647 | 8.29B |
| 17 | TWST | Twist Bioscience Corporation | 8.83B | -3.29% | 1,804,757 | 431.80M |
| 18 | QGEN | Qiagen N.V. | 8.64B | -5.20% | 8,620,805 | 2.10B |
| 19 | RDNT | RadNet, Inc. | 5.88B | -2.77% | 549,475 | 2.27B |
| 20 | SHC | Sotera Health Company | 5.47B | -2.04% | 1,905,689 | 1.22B |
| 21 | BLLN | BillionToOne, Inc. | 4.56B | 1.80% | 548,479 | 397.41M |
| 22 | ADPT | Adaptive Biotechnologies Corporation | 4.08B | -1.69% | 1,694,323 | 308.08M |
| 23 | GRAL | GRAIL, Inc. | 3.42B | -3.72% | 380,897 | 165.26M |
| 24 | VCYT | Veracyte, Inc. | 3.33B | -1.99% | 1,165,420 | 561.90M |
| 25 | WGS | GeneDx Holdings Corp. | 2.54B | -2.15% | 504,317 | 454.43M |
| 26 | CDNA | CareDx, Inc. | 2.46B | -2.28% | 548,607 | 458.09M |
| 27 | NEO | NeoGenomics, Inc. | 2.11B | -3.36% | 1,094,236 | 766.30M |
| 28 | PSNL | Personalis, Inc. | 1.82B | -7.18% | 4,792,841 | 69.67M |
| 29 | FRNM | Freenome, Inc. | 1.48B | -0.22% | 426,160 | 35.41M |
| 30 | OPK | OPKO Health, Inc. | 1.10B | - | 1,919,880 | 587.90M |
| 31 | CSTL | Castle Biosciences, Inc. | 1.02B | -2.13% | 357,665 | 357.28M |
| 32 | FLGT | Fulgent Genetics, Inc. | 535.17M | -2.26% | 259,914 | 323.93M |
| 33 | MYGN | Myriad Genetics, Inc. | 291.73M | -4.69% | 1,352,377 | 806.60M |
| 34 | BDSX | Biodesix, Inc. | 267.89M | -4.66% | 243,928 | 102.94M |
| 35 | XGN | Exagen Inc. | 185.32M | -3.41% | 305,440 | 71.12M |
| 36 | IMDX | Insight Molecular Diagnostics Inc. | 141.37M | -0.46% | 83,104 | 1.67M |
| 37 | QUCY | Quantum Cyber N.V. | 110.13M | 0.77% | 566,165 | 537.08K |
| 38 | BNR | Burning Rock Biotech Limited | 108.84M | 5.52% | 1,502 | 74.58M |
| 39 | MDXH | MDxHealth SA | 70.73M | -0.24% | 398,694 | 114.02M |
| 40 | PRPO | Precipio, Inc. | 55.71M | 2.20% | 29,682 | 27.20M |
| 41 | ADVB | Advanced Biomed Inc. | 13.25M | -1.47% | 190,811 | - |
| 42 | MBAI | Check-Cap Ltd. | 8.88M | - | 15,187 | - |
| 43 | XWEL | XWELL, Inc. | 8.59M | -3.85% | 45,785 | 28.28M |
| 44 | NDRA | ENDRA Life Sciences Inc. | 6.84M | 1.56% | 7,270 | - |
| 45 | ISPC | iSpecimen Inc. | 3.95M | -7.10% | 247,094 | 466.30K |
| 46 | BIAF | bioAffinity Technologies, Inc. | 3.14M | -3.00% | 165,138 | 5.90M |